Literature DB >> 19337272

Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes.

John D Baxter1, Paul Webb.   

Abstract

Thyroid hormones influence heart rate, serum lipids, metabolic rate, body weight and multiple aspects of lipid, carbohydrate, protein and mineral metabolism. Although increased thyroid hormone levels can improve serum lipid profiles and reduce fat, these positive effects are counterbalanced by harmful effects on the heart, muscle and bone. Thus, attempts to use thyroid hormones for cholesterol-lowering and weight loss purposes have so far been limited. However, over the past decade, thyroid hormone analogues that are capable of uncoupling beneficial effects from deleterious effects have been developed. Such drugs could serve as powerful new tools to address two of the largest medical problems in developed countries--atherosclerosis and obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337272     DOI: 10.1038/nrd2830

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  87 in total

Review 1.  Selective thyroid hormone receptor modulators.

Authors:  Hikari A I Yoshihara; Thomas S Scanlan
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

Review 2.  New targets of high-density lipoprotein therapy.

Authors:  Stephen J Nicholls; Steven E Nissen
Journal:  Curr Opin Lipidol       Date:  2007-08       Impact factor: 4.776

Review 3.  Deiodinases: implications of the local control of thyroid hormone action.

Authors:  Antonio C Bianco; Brian W Kim
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

4.  The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus.

Authors:  Luis Henrique Canani; Clarissa Capp; José Miguel Dora; Erika L Souza Meyer; Márcia S Wagner; John W Harney; P Reed Larsen; Jorge L Gross; Antonio C Bianco; Ana Luiza Maia
Journal:  J Clin Endocrinol Metab       Date:  2005-03-29       Impact factor: 5.958

5.  The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity.

Authors:  S U Trost; E Swanson; B Gloss; D B Wang-Iverson; H Zhang; T Volodarsky; G J Grover; J D Baxter; G Chiellini; T S Scanlan; W H Dillmann
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

Review 6.  Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression.

Authors:  Luis A Videla; Virginia Fernández; Gladys Tapia; Patricia Varela
Journal:  Front Biosci       Date:  2007-01-01

7.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

Review 8.  Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

Authors:  R Ara; I Tumur; A Pandor; A Duenas; R Williams; A Wilkinson; S Paisley; J Chilcott
Journal:  Health Technol Assess       Date:  2008-05       Impact factor: 4.014

Review 9.  Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases.

Authors:  Laura Calabresi; Cesare R Sirtori; Rodolfo Paoletti; Guido Franceschini
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

10.  Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats.

Authors:  Andrea Perra; Gabriella Simbula; Michela Simbula; Monica Pibiri; Marta A Kowalik; Pia Sulas; Maria T Cocco; Giovanna M Ledda-Columbano; Amedeo Columbano
Journal:  FASEB J       Date:  2008-04-23       Impact factor: 5.191

View more
  89 in total

1.  Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance.

Authors:  François R Jornayvaz; Hui-Young Lee; Michael J Jurczak; Tiago C Alves; Fitsum Guebre-Egziabher; Blas A Guigni; Dongyan Zhang; Varman T Samuel; J Enrique Silva; Gerald I Shulman
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  Metabolic disorders: Heart microRNA provides new route to metabolic control.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

Review 3.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

Review 4.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

5.  Regulation of thyroid hormone activation via the liver X-receptor/retinoid X-receptor pathway.

Authors:  Marcelo A Christoffolete; Márton Doleschall; Péter Egri; Zsolt Liposits; Ann Marie Zavacki; Antonio C Bianco; Balázs Gereben
Journal:  J Endocrinol       Date:  2010-02-22       Impact factor: 4.286

6.  Thyroid hormone induction of human cholesterol 7 alpha-hydroxylase (Cyp7a1) in vitro.

Authors:  Jan A Lammel Lindemann; Anusha Angajala; David A Engler; Paul Webb; Stephen D Ayers
Journal:  Mol Cell Endocrinol       Date:  2014-02-25       Impact factor: 4.102

7.  Thyroid hormone receptor beta and NCOA4 regulate terminal erythrocyte differentiation.

Authors:  Xiaofei Gao; Hsiang-Ying Lee; Wenbo Li; Randall Jeffrey Platt; M Inmaculada Barrasa; Qi Ma; Russell R Elmes; Michael G Rosenfeld; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-01       Impact factor: 11.205

8.  Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells.

Authors:  Fabrice Chatonnet; Romain Guyot; Gérard Benoît; Frederic Flamant
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 9.  Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Trends Endocrinol Metab       Date:  2009-12-16       Impact factor: 12.015

10.  Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms.

Authors:  Alok Mishra; Xu-Guang Zhu; Kai Ge; Sheue-Yann Cheng
Journal:  J Mol Endocrinol       Date:  2010-01-15       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.